MedTrace Logo

The Value of Short-term Pain Relief for the Prediction of Long-term Outcome After Cervical or Lumbar Nerve Root Infiltration

NCT01945554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-01-25

No results posted yet for this study

Summary

The purpose if this study is to assess the response to nerve root infiltration therapy in patients with cervical or lumbar disc herniations.

Conditions

  • Cervical Disc Herniation
  • Lumbar Disc Herniation

Interventions

PROCEDURE

Cervical nerve root infiltration

4mg Mephamesone followed by 1ml of 0.5% bupivacaine (Bupivacain®) will be administered.

PROCEDURE

Lumbar nerve root infiltration

40mg triamzinolone (Kenacort®) followed by 2ml of 0.5% bupivacaine (Bupivacain®) will be administered.

DRUG

Mephamesone

DRUG

0.5% bupivacaine (Bupivacain®)

DRUG

Kenacort®

Sponsors & Collaborators

  • Holger Joswig

    lead OTHER

Principal Investigators

  • Holger Joswig, M.D. · Cantonal Hospital St. Gallen, Dept. of Neurosurgery

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01945554 on ClinicalTrials.gov